AstraZeneca lifts 2024 outlook, doubles down on US plans | REUTERS

From Reuters.

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year, helped by strong demand for its cancer and rare-diseases medicines, after third-quarter results beat estimates.

#astrazeneca #results #profit #News #Reuters #Newsfeed

Read the story here: https://reut.rs/3O2BnBl

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en